Welcome to Our Blog
We started this blog to bring more awareness and understanding of autoimmune disease, which is so common, yet often so misunderstood. According to the American Autoimmune Related Diseases Association, only 13 percent of Americans can name one autoimmune disease! We saw the need for an expert resource to counter this lack of understanding.
The purpose of this blog is to build a community for people living with these lifelong, chronic diseases, their families and friends who love and support them, as well as anyone interested in learning more about these complex conditions.
We will bring you the voices of people living with or caring for those with these diseases, as well as the researchers and clinicians fighting for cures day in and day out. As leaders in this fight, we’ll provide regular research updates and developments led by BRI and our partner organizations that show progress in the fight against autoimmune disease from the lab, to the clinic, and ultimately to treatments and cures for patients.
Join Us
Share your stories. Leave comments. Ask questions. We’re here to listen, share and help each other understand and bring greater visibility to these often invisible, yet devastating conditions.
Follow us on Facebook and Instagram and sign up for our newsletter so you won’t miss any important updates!
We are your partner in this battle – Join the Fight!
You Might Also Like
Innovation Fund Spotlight: New Tool Enables Scientists to Collect More Data From Rare Cells
Scientists know that cells of the immune system attack healthy tissue in autoimmune disease. But they don’t know exactly when those cells go awry, what drives them toward disease or if that process can be slowed or stopped to prevent disease. BRI has been instrumental in research that led to the first medicine to delay the onset of type 1 diabetes. Now, Peter Morawski, PhD, and Arpit Mishra, PhD, are building on that work and exploring early intervention in other autoimmune diseases.
Innovation Fund Spotlight: Finding the Precise Moment When Immune Cells Start Causing Disease
Autoimmune diseases happen when immune cells, which are supposed to protect you from germs, mistakenly attack healthy tissues. But what if we knew exactly which immune cells would attack – and when? Could we stop that attack before it starts? BRI’s John Ray, PhD, and Oliver Harrison, DPhil, are exploring exactly that.
Innovation Fund Spotlight: Pioneering a New Generation of Tetramers
In the late 1990s, Bill Kwok, PhD, pioneered MHC class II tetramers, a game-changing tool in immunology research. Tetramers have fueled countless research breakthroughs because they enable scientists to find extremely rare cells and extract them to study in precise detail.
Immuno-what? Hear the latest from BRI
Keep up to date on our latest research, new clinical trials and exciting publications.